 |
市场调查报告书
商品编码
1567141
熊去氧胆酸市场：按剂型、按提取方法、按应用、按分销管道、按地区Ursodeoxycholic Acid Market, By Dosage Form, By Mode of Extraction, By Application, By Distribution Channel, By Geography |
||||||
预计 2024 年全球熊去氧胆酸市场规模为 5.901 亿美元，预计 2031 年将达到 11.652 亿美元，2024 年至 2031 年复合年增长率为 10.2%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 5.901 亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024年至2031年 |
| 预测 2024-2031 年复合年增长率： | 10.20% | 2031年价值预测 | 11.652 亿美元 |
熊去氧胆酸是肝臟产生的胆汁酸，有助于消化和吸收摄取的脂肪。它用于治疗各种与肝臟相关的疾病，例如原发性胆汁性肝硬化（PBC）和胆结石。全球熊去氧胆酸市场的成长是由于肝臟疾病盛行率的上升以及人们对熊去氧胆酸治疗益处的认识不断提高而推动的。市场相关人员正在大力投资研发，以开发熊去氧胆酸的新配方和开拓形式，并扩大消费群。
市场动态：
全球熊去氧胆酸市场的成长是由于越来越多的老年人更容易受到肝损伤、新兴市场医疗保健支出的增加以及越来越多地采用熊去氧胆酸作为治疗原发性胆汁性胆管炎的第一线药物。然而，高昂的治疗成本和替代治疗方案的存在可能会阻碍市场成长。针对特定适应症的熊去氧胆酸製剂的市场开拓以及提高生物有效性的新技术的出现为市场参与者提供了高成长机会。严格的药品审批法规可能会阻碍市场成长。
本研究的主要特点
该报告对熊去氧胆酸的全球市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。
它揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球熊去氧胆酸市场的主要企业。
本研究涵盖的主要企业包括 Dr. Falk Pharma、Daewoong Pharmaceutical、Teva Pharmaceutical、Mitsubishi Tanabe Pharma 和 Lannett Company。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球熊去氧胆酸市场报告迎合了该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过分析全球熊去氧胆酸市场时使用的各种策略矩阵来促进他们的决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规及趋势分析
- 市场动态
- 促进因素
- 抑制因素
- 机会
- 影响分析
- 市场趋势
- 主要进展
- 监管场景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
第四章全球熊去氧胆酸市场－冠状病毒（COVID-19）大流行的影响
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第五章全球熊去氧胆酸市场，按剂型，2019-2031，（百万美元）
- 固态剂型
- 液体剂型
第 6 章：2019-2031 年全球熊去氧胆酸市场（以萃取方法）（百万美元）
- 合成
- 生物
第七章熊去氧胆酸全球市场，依应用分类，2019-2031，（百万美元）
- 胃肠道疾病
- 肝臟疾病
- 囊肿纤维化
- 其他的
第8章全球熊去氧胆酸市场，依通路，2019-2031年，（百万美元）
- 医院药房
- 零售药房
- 网路药房
第9章熊去氧胆酸全球市场，按地区，2019-2031，（百万美元）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第10章竞争格局
- 公司简介
- Dipharma Francis Srl
- ERREGIERRE SpA
- Grindeks
- Industria Chimica Emiliana
- Mitsubishi Tanabe Pharma Corporation
- Zhongshan Belling Biotechnology Co.
- Glenmark Pharmaceutical Limited
- Abil Chempharma Private Limited
- Biotavia Labs Pvt Ltd
- Daewoong Bio Inc.
- PharmaZell GmbH
- Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
- Dr. Falk Pharma
- Teva Pharmaceuticals
- Epic Pharma
- Lannett Company, Inc.
- Mylan NV
- Bruschettini SpA
- Impax Laboratories, Inc.
- Shanghai Pharma
第十一章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第十二章参考文献与调查方法
- 参考
- 调查方法
Global ursodeoxycholic acid market is estimated to be valued at USD 590.1 Mn in 2024 and is expected to reach USD 1,165.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 590.1 Mn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 10.20% | 2031 Value Projection: | US$ 1,165.2 Mn |
Ursodeoxycholic acid is a bile acid produced by the liver that helps in digestion and absorption of consumed fats. It is prescribed for treating various liver related conditions such as primary biliary cirrhosis (PBC) and gallstones. Global ursodeoxycholic acid market growth is driven by rising prevalence of liver diseases and increasing awareness about benefits of ursodeoxycholic acid in their treatment. The market players are investing heavily in R&D to develop new formulations and delivery forms of ursodeoxycholic acid to expand consumer base.
Market Dynamics:
Global ursodeoxycholic acid market growth is driven by rising geriatric population prone to developing liver disorders, increasing healthcare expenditure in developing nations, and growing adoption of ursodeoxycholic acid as first line therapy for PBC. However, high treatment costs and availability of alternative treatment options can hamper the market growth. Development of ursodeoxycholic acid formulations targeted towards specific indications and emergence of novel technologies for enhancing its bioavailability present high growth opportunities for market players. Stringent regulations for drug approvals can hamper the market growth.
Key features of the study:
This report provides in-depth analysis of the global ursodeoxycholic acid market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global ursodeoxycholic acid market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Dr. Falk Pharma, Daewoong Pharmaceutical, Teva Pharmaceutical, Mitsubishi Tanabe Pharma, and Lannett Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global ursodeoxycholic acid market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ursodeoxycholic acid market
Detailed Segmentation-
- Dosage Form Insights (Revenue, USD Mn, 2019 - 2031)
- Solid Dosage Form
- Liquid Dosage Form
- Mode of Extraction Insights (Revenue, USD Mn, 2019 - 2031)
- Synthetic
- Biological
- Application Insights (Revenue, USD Mn, 2019 - 2031)
- Gastrointestinal Disorders
- Liver Disorders
- Cystic Fibrosis
- Others
- Distribution Channel Insights (Revenue, USD Mn, 2019 - 2031)
- Hospitals and Clinics
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Mn 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Dipharma Francis Srl
- ERREGIERRE S.p.A.
- Grindeks
- Industria Chimica Emiliana
- Mitsubishi Tanabe Pharma Corporation
- Zhongshan Belling Biotechnology Co.
- Glenmark Pharmaceutical Limited
- Abil Chempharma Private Limited
- Biotavia Labs Pvt Ltd
- Daewoong Bio Inc.
- PharmaZell GmbH
- Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
- Falk Pharma
- Teva Pharmaceuticals
- Epic Pharma
- Lannett Company, Inc.
- Mylan N.V.
- Bruschettini S.p.A.
- Impax Laboratories, Inc.
- Shanghai Pharma
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Dosage Form
- Market Snapshot, By Mode of Extraction
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Ursodeoxycholic Acid Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Ursodeoxycholic Acid Market, By Dosage Form, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Solid Dosage Form
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Liquid Dosage Form
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global Ursodeoxycholic Acid Market, By Mode of Extraction, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Synthetic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Biological
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
7. Global Ursodeoxycholic Acid Market, By Application, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Gastrointestinal Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Liver Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Cystic Fibrosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
8. Global Ursodeoxycholic Acid Market, By Distribution Channel, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
9. Global Ursodeoxycholic Acid Market, By Region, 2019 - 2031, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Dipharma Francis Srl
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ERREGIERRE S.p.A.
- Grindeks
- Industria Chimica Emiliana
- Mitsubishi Tanabe Pharma Corporation
- Zhongshan Belling Biotechnology Co.
- Glenmark Pharmaceutical Limited
- Abil Chempharma Private Limited
- Biotavia Labs Pvt Ltd
- Daewoong Bio Inc.
- PharmaZell GmbH
- Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
- Dr. Falk Pharma
- Teva Pharmaceuticals
- Epic Pharma
- Lannett Company, Inc.
- Mylan N.V.
- Bruschettini S.p.A.
- Impax Laboratories, Inc.
- Shanghai Pharma
- Dipharma Francis Srl
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
